Physician profile
Daniel L Schipper
NPI 1437392750
$4,145.71
in general payments reported to CMS, 2019-2025
12 companies · $3,711 in 2025
The $3,711 reported for 2025 was more than what 98% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $232 · 2022: $127 · 2023: $58.83 · 2024: $16.72 · 2025: $3,711.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,450 · Travel and Lodging: $181 · Food and Beverage: $155.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,450.00 |
| Travel and Lodging | $181.27 |
| Food and Beverage | $155.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $3,631.27 | 2025 | |
| Abbott Laboratories | $125.28 | 2021-2024 | Esprit |
| Janssen Pharmaceuticals, INC | $78.16 | 2021-2022 | |
| Impulse Dynamics (USA) INC. | $74.15 | 2022-2023 | Optimizer |
| Boston Scientific Corporation | $47.52 | 2021-2025 | Emblem Mri S-Icd, Bodyguardian |
| Merck Sharp & Dohme LLC | $46.29 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $34.22 | 2021-2023 | Lifevest |
| Baxter Healthcare | $31.79 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Amgen INC. | $29.15 | 2021-2025 | Repatha |
| Astellas Pharma US INC | $18.63 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $15.84 | 2025 | Eliquis |
| Astrazeneca Pharmaceuticals LP | $13.41 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Schipper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.